Cargando…

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin

Background Disseminated intravascular coagulation (DIC) is not a homogeneous condition, but rather includes heterogeneous conditions, and its pathophysiology and outcome vary considerably depending on the background. Although anticoagulant therapy is expected to be of benefit in the treatment of DI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Hideo, Kawasugi, Kazuo, Honda, Goichi, Kawano, Noriaki, Uchiyama, Toshimasa, Madoiwa, Seiji, Takezako, Naoki, Suzuki, Kei, Seki, Yoshinobu, Ikezoe, Takayuki, Iba, Toshiaki, Okamoto, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946787/ https://www.ncbi.nlm.nih.gov/pubmed/36846833 http://dx.doi.org/10.1055/a-2009-9073

Ejemplares similares

Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis
por: Wada, Hideo, et al.
Publicado: (2020)

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa
por: Kawasugi, Kazuo, et al.
Publicado: (2021)

Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment—A Cohort Study Using a Postmarketing Surveillance Database
por: Yoshinobu, Seki, et al.
Publicado: (2021)

Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure
por: Kawano, Noriaki, et al.
Publicado: (2020)

Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022)

Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
por: Iba, Toshiaki, et al.
Publicado: (2018)

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
por: Asakura, Hidesaku, et al.
Publicado: (2016)

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
por: Wada, Hideo, et al.
Publicado: (2017)

Successful use of an antithrombin for heparin resistance with andexanet alfa
por: Honda, Jun, et al.
Publicado: (2023)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
por: Iba, Toshiaki, et al.
Publicado: (2009)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
por: Nakahara, Kazunari, et al.
Publicado: (2013)

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity
por: Iba, Toshiaki, et al.
Publicado: (2016)

Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis
por: Wada, Takeshi, et al.
Publicado: (2022)

Analysis of CRP, Antithrombin, Fibrinogen, and Hematological Changes in 433 Patients with PTE
por: Wu, Yu-Yan, et al.
Publicado: (2021)

Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation
por: Morita, Nozomi, et al.
Publicado: (2018)

Acute Portal Vein Thrombosis Treated with Recombinant Human Soluble Thrombomodulin Combined with Antithrombin III
por: Nakayama, Satoshi, et al.
Publicado: (2020)

Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)

Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation
por: Negreva, Mariya, et al.
Publicado: (2016)

Genetic Analysis of a Pedigree With Antithrombin and Prothrombin Compound Mutations and Antithrombin Heterozygotes
por: Zhang, Haiyue, et al.
Publicado: (2022)

Marked reductions of protein C and antithrombin in post-trauma DIC have close relations with MODS and poor outcome
por: Gando, S, et al.
Publicado: (2002)

Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation
por: Umegaki, Takeshi, et al.
Publicado: (2020)

Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014)

A TEST FOR ANTITHROMBIN IN THE BLOOD
por: Hess, Alfred F.
Publicado: (1915)

Direct antimicrobial activity of antithrombin?
por: Wiedermann, Christian J, et al.
Publicado: (2010)

Defects of splicing in antithrombin deficiency
por: de la Morena‐Barrio, María E., et al.
Publicado: (2017)

Performance evaluation of thrombomodulin, thrombin‐antithrombin complex, plasmin‐α2‐antiplasmin complex, and t‐PA: PAI‐1 complex
por: Chen, Qian, et al.
Publicado: (2019)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers
por: Furuie, Hidetoshi, et al.
Publicado: (2019)

Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC
por: Madoiwa, Seiji
Publicado: (2015)

Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
por: Umemura, Yutaka, et al.
Publicado: (2018)

Antithrombin and free tri-iodothyronine in sepsis
por: Mateu, P, et al.
Publicado: (2004)

Inhibition of HCV by the serpin antithrombin III
por: Asmal, Mohammed, et al.
Publicado: (2012)

Proper diagnosis of antithrombin III deficiency
por: Özdemir, Zehra Narlı, et al.
Publicado: (2017)

Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow
por: Loncar, Robert, et al.
Publicado: (2006)

Fibrinogen and antithrombin III are associated with in-hospital mortality among critically ill patients with acute kidney injury
por: Zhang, Guangyuan, et al.
Publicado: (2022)

A case of antithrombin replacement using recombinant human antithrombin in an adult patient supported with extracorporeal membrane oxygenation
por: Lavandosky, Gerald J
Publicado: (2015)

Insight into Residues Critical for Antithrombin Function from an Expanded Database of Sequences That Includes Frog, Turtle and Ostrich Antithrombins
por: Backovic, Marija, et al.
Publicado: (2002)

Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
por: Gindele, Réka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_05jndphd6bij7l92e2uomh8hup